118 related articles for article (PubMed ID: 33617649)
1. Comment on: SMARCB1 Gene Mutation Predisposes to Earlier Development of Glioblastoma: A Case Report of Familial GBM.
Smith MJ; Pathmanaban ON; Coope DJ; King AT; Evans DG
J Neuropathol Exp Neurol; 2021 Feb; 80(3):289-290. PubMed ID: 33617649
[No Abstract] [Full Text] [Related]
2. Authors' Reply: SMARCB1 Gene Mutation Predisposes to Earlier Development of Glioblastoma: A Case Report of Familial GBM.
Fonkem E; Peng S; Berens M; Mukherjee S
J Neuropathol Exp Neurol; 2021 Feb; 80(3):290-291. PubMed ID: 33617648
[No Abstract] [Full Text] [Related]
3. SMARCB1 Gene Mutation Predisposes to Earlier Development of Glioblastoma: A Case Report of Familial GBM.
Mukherjee S; Stroberg E; Wang F; Morales L; Shan Y; Rao A; Huang JH; Wu E; Fonkem E
J Neuropathol Exp Neurol; 2020 May; 79(5):562-565. PubMed ID: 32296843
[TBL] [Abstract][Full Text] [Related]
4. Germline SMARCB1 mutation predisposes to multiple meningiomas and schwannomas with preferential location of cranial meningiomas at the falx cerebri.
van den Munckhof P; Christiaans I; Kenter SB; Baas F; Hulsebos TJ
Neurogenetics; 2012 Feb; 13(1):1-7. PubMed ID: 22038540
[TBL] [Abstract][Full Text] [Related]
5. SMARCB1 mutations are not a common cause of multiple meningiomas.
Hadfield KD; Smith MJ; Trump D; Newman WG; Evans DG
J Med Genet; 2010 Aug; 47(8):567-8. PubMed ID: 20472658
[TBL] [Abstract][Full Text] [Related]
6. Frequency of SMARCB1 mutations in familial and sporadic schwannomatosis.
Smith MJ; Wallace AJ; Bowers NL; Rustad CF; Woods CG; Leschziner GD; Ferner RE; Evans DG
Neurogenetics; 2012 May; 13(2):141-5. PubMed ID: 22434358
[TBL] [Abstract][Full Text] [Related]
7. SMARCB1-mediated SWI/SNF complex function is essential for enhancer regulation.
Wang X; Lee RS; Alver BH; Haswell JR; Wang S; Mieczkowski J; Drier Y; Gillespie SM; Archer TC; Wu JN; Tzvetkov EP; Troisi EC; Pomeroy SL; Biegel JA; Tolstorukov MY; Bernstein BE; Park PJ; Roberts CW
Nat Genet; 2017 Feb; 49(2):289-295. PubMed ID: 27941797
[TBL] [Abstract][Full Text] [Related]
8. Comment on the article "Germline SMARCB1 mutation predisposes to multiple meningiomas and schwannomas with preferential location of cranial meningiomas at the falx cerebri" by van den Munckhof et al.
Prescott TE; Smith MJ; Evans DG
Neurogenetics; 2012 Feb; 13(1):103-4. PubMed ID: 22203059
[No Abstract] [Full Text] [Related]
9. [Clinicopathological features for epithelioid glioblastoma: A newly defined tumor by the 2016 World Health Organization Classification of Tumors of the Central Nervous System].
Li J; Ling X; Lai M; Hu Q; Shan C; Cai L
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2018 Apr; 43(4):398-402. PubMed ID: 29774876
[TBL] [Abstract][Full Text] [Related]
10. A mosaic pattern of INI1/SMARCB1 protein expression distinguishes Schwannomatosis and NF2-associated peripheral schwannomas from solitary peripheral schwannomas and NF2-associated vestibular schwannomas.
Caltabiano R; Magro G; Polizzi A; Praticò AD; Ortensi A; D'Orazi V; Panunzi A; Milone P; Maiolino L; Nicita F; Capone GL; Sestini R; Paganini I; Muglia M; Cavallaro S; Lanzafame S; Papi L; Ruggieri M
Childs Nerv Syst; 2017 Jun; 33(6):933-940. PubMed ID: 28365909
[TBL] [Abstract][Full Text] [Related]
11. Molecular characterisation of SMARCB1 and NF2 in familial and sporadic schwannomatosis.
Hadfield KD; Newman WG; Bowers NL; Wallace A; Bolger C; Colley A; McCann E; Trump D; Prescott T; Evans DG
J Med Genet; 2008 Jun; 45(6):332-9. PubMed ID: 18285426
[TBL] [Abstract][Full Text] [Related]
12. Schwannomatosis associated with multiple meningiomas due to a familial SMARCB1 mutation.
Bacci C; Sestini R; Provenzano A; Paganini I; Mancini I; Porfirio B; Vivarelli R; Genuardi M; Papi L
Neurogenetics; 2010 Feb; 11(1):73-80. PubMed ID: 19582488
[TBL] [Abstract][Full Text] [Related]
13. Evidence of a four-hit mechanism involving SMARCB1 and NF2 in schwannomatosis-associated schwannomas.
Sestini R; Bacci C; Provenzano A; Genuardi M; Papi L
Hum Mutat; 2008 Feb; 29(2):227-31. PubMed ID: 18072270
[TBL] [Abstract][Full Text] [Related]
14. RNA-based analysis of two SMARCB1 mutations associated with familial schwannomatosis with meningiomas.
Melean G; Velasco A; Hernández-Imaz E; Rodríguez-Álvarez FJ; Martín Y; Valero A; Hernández-Chico C
Neurogenetics; 2012 Aug; 13(3):267-74. PubMed ID: 22752724
[TBL] [Abstract][Full Text] [Related]
15. An unusual case of schwannomatosis with bilateral maxillary sinus schwannomas and a novel SMARCB1 gene mutation.
Toms J; Harrison J; Richard H; Childers A; Reiter ER; Graham RS
J Neurosurg Spine; 2016 Jan; 24(1):160-6. PubMed ID: 26431068
[TBL] [Abstract][Full Text] [Related]
16. Desmoplastic myxoid tumor, SMARCB1-mutant: a new variant of SMARCB1-deficient tumor of the central nervous system preferentially arising in the pineal region.
Matsumura N; Goda N; Yashige K; Kitagawa M; Yamazaki T; Nobusawa S; Yokoo H
Virchows Arch; 2021 Oct; 479(4):835-839. PubMed ID: 33420834
[TBL] [Abstract][Full Text] [Related]
17. Atypical teratoid/rhabdoid tumors (ATRTs) with SMARCA4 mutation are molecularly distinct from SMARCB1-deficient cases.
Holdhof D; Johann PD; Spohn M; Bockmayr M; Safaei S; Joshi P; Masliah-Planchon J; Ho B; Andrianteranagna M; Bourdeaut F; Huang A; Kool M; Upadhyaya SA; Bendel AE; Indenbirken D; Foulkes WD; Bush JW; Creytens D; Kordes U; Frühwald MC; Hasselblatt M; Schüller U
Acta Neuropathol; 2021 Feb; 141(2):291-301. PubMed ID: 33331994
[TBL] [Abstract][Full Text] [Related]
18. A case of desmoplastic myxoid tumor, SMARCB1 mutant, in the pineal region.
Wang YE; Chen JJ; Wang W; Zhang AL; Zhou W; Wu HB
Neuropathology; 2021 Feb; 41(1):37-41. PubMed ID: 32901946
[TBL] [Abstract][Full Text] [Related]
19. Functional relevance of genes predicted to be affected by epigenetic alterations in atypical teratoid/rhabdoid tumors.
Tegeder I; Thiel K; Erkek S; Johann PD; Berlandi J; Thatikonda V; Frühwald MC; Kool M; Jeibmann A; Hasselblatt M
J Neurooncol; 2019 Jan; 141(1):43-55. PubMed ID: 30446899
[TBL] [Abstract][Full Text] [Related]
20. Coexistence of schwannomatosis and glioblastoma in two families.
Deiller C; Van-Gils J; Zordan C; Tinat J; Loiseau H; Fabre T; Delleci C; Cohen J; Vidaud M; Parfait B; Goizet C
Eur J Med Genet; 2019 Aug; 62(8):103680. PubMed ID: 31128261
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
